MedPath

Examining the Impact of Family Connectors

Not Applicable
Completed
Conditions
Caregiver Stress Syndrome
Registration Number
NCT05195489
Lead Sponsor
NYU Langone Health
Brief Summary

The purpose of this study is to understand the impact of Family Connectors, a peer-to-peer support and education program for family members who have participated in OnTrackNY, a treatment program for adolescents and young adults.

Detailed Description

The study objectives are to examine the association between involvement in Family Connectors, a manualized peer-to-peer support and education program for family members of adolescents or young adults with symptoms of first episode psychosis, and feelings of empowerment, self-efficacy and social support.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  • English speaking, due to the study materials not being validated in other languages.
  • 18 years of age or older,
  • Family member of adolescents/young adults with first episode psychosis who participated in OnTrackNY.
Exclusion Criteria
  • Does not provide informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in perceived social supportMonth 1, Month 7

Perceived social support is measured by a 13-item self-reported questionnaire. The subject is asked to rate each statement about social support on a scale of 1-7 (1=very strongly disagree, 2=strongly disagree, 3=disagree, 4=neither agree nor disagree, 5=agree, 6=strongly agree, 7=very strongly agree). Scores range from 13-91. Higher scores indicate stronger social support.

Change in caregiver strainMonth 1, Month 7

Caregiver strain is measured by a 10-tiem self-reported questionnaire. The subject is asked to rate each statement relating to caregiver strain on a scale of 1-5 (1=not at all, 2=a little, 3=somewhat, 4=Quite a bit, 5=very much). Scores range from 10-50, with higher scores indicating high caregiver strain.

Change in perceived self-efficacyMonth 1, Month 7

Perceived self-efficacy is measured by a 7-tiem self-reported questionnaire. The subject is asked to rate each statement on a scale of 1-5 (1=strongly disagree, 2=disagree, 3=neither agree nor disagree, 4=agree, 5=strongly agree). Scores range from 7-35, with higher scores indicating greater perceived self-efficacy.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NYU Langone Health

🇺🇸

New York, New York, United States

NYU Langone Health
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.